It is well known that some pathogenic cells have enhanced glycolysis, the regulatory network leading to increased glycolysis are not well characterized.
Introduction
TH17 cells, which have been characterized as a subset of effector CD4 + helper T cells that produce IL-17A (Littman and Rudensky, 2010) , mediate barrier tissue integrity, mucosal defence, and also contribute to the development of multiple autoimmune diseases. At steady-state condition, TH17 cells producing IL-10 are mainly found at sites of intestinal lamina propria (Ivanov et al., 2009; Sano et al., 2015) . Under autoimmune or pathogen infection condition, TH17 cells acquire the capability to produce IFNγ or GM-CSF, and are often seen at sites of inflamed loci (Atarashi et al., 2015; Stockinger and Omenetti, 2017) .
TH17 cells also could be differentiated in vitro by a combination of cytokines, either by TGF-β1 plus IL-6 (TH17 (β), nonpathogenic) or by IL-6 plus IL-1β and architecture of TH17 cells in vivo is unknown, and signaling pathways that induce TH17 cell chromatin remodeling are also incompletely understood.
TGF-β1 is a cytokine with immunosuppressive properties and its loss is associated with fatal autoimmune pathologies (Fontenot et al., 2003; Gorelik and Flavell, 2000; Shull et al., 1992) . TGF-β1 is secreted by multiple cell types, including regulatory T cells, fibroblasts, and epithelial cells. It signals through a receptor complex of TGF-βRII and TGF-βRI to trigger the phosphorylation of Smad proteins, which then act to induce and repress specific target genes (Tu et al., 2018) . TGF-β1, at a lower concentration, promotes nonpathogenic TH17 cell differentiation in vitro (Ghoreschi et al., 2010; McGeachy et al., 2007) , however, at a relatively higher concentration, it readily induces Treg cells (Li and Flavell, 2008) . However, the precise mechanism by which TGF-β1 regulates TH17 cell function remains poorly understood.
In this study, first by global transcriptional analyses we demonstrate that homeostatic TH17 cells derived in vivo show repressed glycolytic pathway gene expression. Further by bioenergetic and metabolomics study we demonstrate that in vitro derived nonpathogenic TH17 (β) cells show reduced glycolytic activity compared to pathogenic TH17 (23) Mechanistic studies reveal TGF-β1 signaling induces TH17 cell chromatin remodeling and represses c-Rel-mediated glycolysis to maintain metabolic quiescence of nonpathogenic TH17 cells. A miR-21-Peli1-c-Rel loop was further identified to be essential for glycolysis of pathogenic TH17 cells.
Results

Homeostatic TH17 cells show repressed glycolysis pathway gene expression
To gain insight of the metabolic states of TH17 cells in vivo, we sorted GFP + TH17 cells from homeostatic ileum and inflamed CNS of EAE mice ( Figure S1A ).
Then we sent ileum and CNS-infiltrated TH17 cells for RNA-seq analyses. We found 1415 upregulated genes and 1249 downregulated genes in CNSinfiltrated TH17 cells compared to ileum TH17 cells (Figure S1B-C). GO and Pathway analyses indicate that several immune pathways were activated in CNS-infiltrated TH17 cells as reported (Gaublomme et al., 2015) , interestingly, we found multiple metabolic pathways were enriched ( Figure 1A -F, Figure S1D ).
We found homeostatic ileum TH17 cells express great more Foxp1 gene ( Figure   1A ), which is critical for maintenance of the metabolic quiescence of naive T cells (Feng et al., 2011; Stephen et al., 2014) . Ileum homeostatic TH17 cells also express several transcription factors with repressor activity c-Maf and Foxo1, and Foxo1 was a repressor of glucose metabolism (Wilhelm et al., 2016) ( Figure 1A) , which is consistent with our finding that CNS-infiltrated TH17 cells express higher level of glycolysis pathway genes ( Figure 1B -D, Figure S1D ), whereas ileum TH17 cells show higher enrichment of glutaminolysis pathway genes. Taken together, these data suggest that TH17 cells in vivo have differential expression of key metabolic pathway genes, with ileum homeostatic TH17 cells show repressed glycolysis pathway gene activation.
Nonpathogenic TH17 cells show reduced glycolytic activity to pathogenic TH17 cells
To study the metabolic activity of TH17 cells more deeply, we induced TH17 cells in vitro by a combination of cytokines TGF-β1, IL-6 (TH17 (β)) or IL-6, IL-1β and IL-23 (TH17 (23)). Interestingly, we consistently observed that TH17 (23) cells show increased cell size compared to TH17 (β) cells ( Figure S2A-B ). We further tested the glycolytic activity of TH17 (β) and TH17 (23) cells by analyzing key metabolic enzyme gene expression, we found TH17 (23) cells express higher glycolytic pathway genes than TH17 (β) cells, TH17 (23) cells express great more Slc2a1/3, Hk2, Tpi1, Aldoa, Eno1, Pkm and Ldha (Figure 2A , Figure S2C ).
We further checked the glycolytic activity of TH17 (β) and TH17 (23) cells by glycolysis stress test, both basal and maximal glycolytic capability were much higher in pathogenic TH17 (23) cells ( Figure 2B ). We next subjected TH17 (β) and TH17 (23) cells for high-resolution metabolomics analyses (Chen et al., 2014; Chen et al., 2016) . Pathogenic TH17 (23) cells were metabolically distinct from TH17 (β) cells ( Figure 2C , Figure   S2D ), and showed higher level intermediates of carbohydrates, amino acids and organic acids, while TH17 (β) cells showed higher level intermediates of nucleotides and fatty acids. Pathway analyses of altered metabolites showed that amino acid, amino sugar metabolism, and glycolytic intermediates trended to be higher in TH17 (23) cells ( Figure 2D , Table S1 ). Taken together, these data suggest that TH17 cells in vitro have distinct metabolic states, nonpathogenic TH17 (β) cells are less glycolytic compared to pathogenic TH17 (23) cells.
Homeostatic TH17 cells show repressed chromatin accessibility at glycolytic genes
To dissect possible regulation mechanism for TH17 cell metabolic reprogramming in vivo, we performed ATAC-seq to assess chromatin landscape genome-wide of TH17 cells derived in vivo ( Figure S3A -C). We found that TH17 cells had discrete chromatin states in vivo ( Figure 3A -B), CNS infiltrating TH17 cells showed great differential global chromatin accessibility compared to ileum homeostatic TH17 cells. Transcriptional factor motif analysis of top 1000 enriched peaks indicated that NF-kB family members (RelA, c-Rel) were repressed in homeostatic TH17 cells ( Figure 3C ). Interestingly, the regulatory region of key TH17 cell-related transcription factors c-Maf and Ahr was with enhanced chromatin accessibility in homeostatic TH17 cells, both c-Maf and Ahr were shown to be critical regulators of TH17 cells ( Figure S3E ).
The regulatory region of metabolic repressor Foxo1 was with reduced chromatin accessibility in CNS-infiltrated TH17 cells, which suggests that CNSinfiltrated TH17 cells were relieved from Foxo1-mediated metabolic repression ( Figure S3E) . A group of genes related to metabolic pathways and solute carrier family members were also with repressed chromatin accessibility in steadystate ileum TH17 cells, which was consistent with the gene expression data ( Figure 3D , Figure S3F ). Taken together, these data suggest that metabolic reprogramming of TH17 cells in vivo were controlled at the epigenetic level, homeostatic TH17 cells show repressed chromatin accessibility at glycolytic genes.
Deregulation of TGF-β1 signaling induces TH17 cell chromatin remodeling at glycolytic genes
To define the regulation mechanism for TH17 cell chromatin remodeling, we differentiated TH17 cells in vitro either in the presence (TH17 (β)) or absence (TH17 (23)) of TGF-β1 and sorted out GFP + TH17 cells, then we performed ATAC-seq to assess chromatin landscape genome-wide ( Figure S4A -B). We found TH17 cells derived in vitro had discrete chromatin states ( Figure 4A ), TH17 (23) cells showed great differential global chromatin accessibility compared to TH17 (β) cells ( Figure 4B ). Transcriptional factor motif analysis of enriched peaks indicated that NF-kB family members were repressed in nonpathogenic TH17 (β) cells derived in the presence of TGF-β1 signaling ( Figure 4C ), which is consistent with the reports that TGF-β1 signaling represses c-Rel activity during lymphocytes activation (Arsura et al., 1996) . A group of genes related to glycolytic pathway were also with decreased chromatin accessibility in TH17 cells derived in the presence of TGF-β1 signaling, which was also consistent with their relative expression level ( Figure 4D , Figure 2A ). Taken together, these data suggest that TGF-β1 signaling represses TH17 cell chromatin accessibility at glycolytic genes for metabolic reprogramming.
TGF-β1 signaling represses c-Rel-mediated glycolysis pathway gene activation in nonpathogenic TH17 cells
Our above data suggested that genes with NF-kB family transcription factors motif were repressed in homeostatic ileum TH17 cells and in vitro-derived nonpathogenic TH17 cells at the chromatin level. To further explore the role of TGF-β1 signaling on NF-kB family transcription factors and its effect on TH17 cell glycolysis, we differentiated TH17 cells in vitro under nonpathogenic TH17 (β) cell condition with variable concentration of mouse recombinant TGF-β1, we found that TGF-β1 signaling inhibited c-Rel expression in a dose-dependent manner, while RelA expression was unchanged at the protein level ( Figure 5A ).
We further checked c-Rel and RelA protein level at in vitro-derived nonpathogenic TH17 (β) and pathogenic TH17 (23) cells, we found pathogenic TH17 (23) cells expressed specifically more c-Rel protein than nonpathogenic TH17 (β) cells ( Figure 5B ). To study whether c-Rel was essential for glycolysis pathway gene activation of pathogenic TH17 cells, we took advantage of a c- Figure 5E , Figure S5A -B), including IL17a, IL17f, Csf2, IL2 and IL23r. And we found enforced expression of c-Rel promoted selected glycolysis pathway gene expression with a level of 20% to 50% upregulation (Hk1, Hk2, Slc2a1 and Slc2a3) ( Figure 5F ), though less pronounced to the level of upregulation of pathogenic TH17 signature genes. We further checked key glycolytic enzymes at the protein level, and we found overexpression of c-Rel elevated Slc2a1 (Glut1) and HK2 ( Figure 5G ). Together, these data suggest that TGF-β1 signaling represses c-Rel-mediated glycolysis of pathogenic TH17 cells.
A miR-21-Peli1-c-Rel loop promotes pathogenic TH17 cell glycolysis
Specific microRNAs are appreciated as key metabolic regulators for immune cell function, to identify microRNAs activated by NF-kB transcription factors that are essential for glycolysis of pathogenic TH17 cells, we checked chromatin accessibility of the regulatory region of microRNAs with NF-kB binding sites and their expression in TH17 cells derived in vivo. We found the regulatory region of a group of microRNAs show great more chromatin accessibility in CNS pathogenic TH17 cells, which include miR-21, miR-23a cluster, miR-146a
( Figure 6A-B) , while miR-21 and miR-146a were the two with the highest abundance in CNS TH17 cells.
Our group previously demonstrated that miR-21 was highly upregulated in inflammatory lesions of multiple human autoimmune diseases (Zhu et al., 2012) .
To better understand the general functional features of miR-21-deficient TH17 cells, we differentiated naïve T cells from control and miR-21 -/mice in vitro under pathogenic TH17 (23) condition, RNA was extracted and subjected to RNA-seq. In the absence of miR-21, TH17 cells showed decreased expression of TH17 cell signature genes, which include lineage-specific transcription factors, cytokines, and cytokine receptors ( Figure 6C-D) . Remarkably, many of the genes involved in glycolytic or related metabolic pathways were highly downregulated, including key transporters for glucose intake, Slc2a1/3, and rate-limiting enzymes, Hk1/2, Pfkl, Pgm2, Ldha and Pdk1 ( Figure 6D) .
Interestingly, many genes of the glycolytic pathway that are highly expressed in CNS-infiltrated pathogenic TH17 cells are generally downregulated in miR-21 -/-TH17 cells ( Figure 6E ). We further checked the glycolytic activity of control and miR-21 -/-TH17 cells by glycolysis stress test, both basal and maximal glycolytic capability were decreased in miR-21 -/-TH17 cells ( Figure 6F ). Taken together, these data suggest that miR-21 promotes glucose metabolism of pathogenic TH17 cells.
To further investigate the precise mechanism underlying how miR-21 promotes pathogenic TH17 cell glucose metabolism, we screened direct targets of miR-21 by combining target prediction with Ago2 HITS-CLIP (Loeb et al., 2012) , TargetScan and RNA-seq data to identify overlapping gene transcripts. Using a combination of these three approaches, we identified 13 common putative targets ( Figure S6A ). Among them, Peli1 has been reported to function as a negative regulator of CD4 + T cell activation by ubiquitination of c-Rel (Chang et al., 2011) , therefore we chose Peli1 for further analysis. By in vitro RIP assay, we found Ago2-immunoprecipitated RNAs had significantly reduced Peli1 mRNA level in miR-21 -/-TH17 (23) cells ( Figure S6B -C), which suggests that Peli1 was a functional target of miR-21 in pathogenic TH17 cells. We further validated these at the protein level in purified GFP + TH17 cells, we found that miR-21 -/-TH17 cells have elevated level of Peli1 protein, whereas the protein level of c-Rel was reduced in miR-21 -/-TH17 cells ( Figure S6D ). Taken together, these data indicate that a miR-21-Peli1-c-Rel loop promotes glycolysis of pathogenic TH17 cells.
Discussion
TH17 cells exhibit great heterogeneity in vivo, the basic energy requirement of TH17 cells for their regulatory or inflammatory function under homeostatic or autoimmune condition was not examined. And how TH17 cells adapt to diverse tissue microenvironment with distinct nutrients availability and regulation of their metabolic reprogramming in vivo were not known.
In the present study, by metabolomics analyses of in vitro derived TH17 cells, we found that TH17 cells respond to different stimulations with distinct metabolic activity. And by global transcriptome analyses of in vivo derived TH17 cells, we first showed TH17 cells adapt to tissue microenvironment with discrete metabolic pathway gene activation in vivo.
To dissect the regulation of TH17 cell metabolic states in vivo, we performed genome-wide chromatin landscape profiling and found that TH17 cells had discrete chromatin states in vivo. The regulatory region of key TH17 cell-related transcription factors, metabolic regulators, metabolism-related genes and microRNAs were with differential chromatin accessibility between homeostatic ileum TH17 cells and CNS infiltrating TH17 cells. Our data suggests that TH17 cells in vivo adapt to distinct microenvironment with discrete epigenetic and metabolic states, and metabolic regulators and metabolism-related genes were regulated at the epigenetic level for their functional requirements. TGF-β1 signaling was further shown to be crucial for remodeling of TH17 cell chromatin states in vitro, c-Rel was identified as an essential metabolic regulator for pathogenic TH17 cells.
Interestingly, we found the conserved regulatory region of a group of small microRNAs were with differential chromatin accessibility of TH17 cells derived in vivo, which could have contributed to the regulation of discrete metabolic states of TH17 cells in vivo for the fine-tune property of microRNAs. The regulatory region of miR-21 was with increased chromatin accessibility in CNS infiltrating TH17 cells. Although miR-21 was shown previously to be important in TH17 cell generation (Murugaiyan et al., 2015) , its exact action has not been well understood. By global transcriptomics analyses, we demonstrate that miR-21 -/-TH17 cells express less TH17 cell signature genes and key metabolism pathway genes. These data suggest that with increased chromatin openness of its regulatory region, miR-21 regulates metabolic reprogramming of TH17 cells under autoimmune inflammation.
TH17 cells mediate pathogenic role in multiple autoimmune diseases. Though anti-IL-17A treatment received great efficacy in psoriasis, it badly failed for IBD patients. Understanding metabolic reprogramming of TH17 cells in vivo may therefore provide more defined therapeutic intervention to TH17 cell mediated autoimmune diseases and insights into TH17 cell mediated host defence. The microenvironment of homeostatic mucosal surfaces and various inflammatory sites could have great differential effects on chromatin states of TH17 cells in vivo, which in turn could facilitate their discrete metabolic reprogramming. Our study so far dissected the metabolic states and chromatin states of TH17 cells in vivo and identified c-Rel as a critical metabolic regulator of pathogenic TH17 cells. 
STAR Methods
Key Resources
Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Nan Shen (nanshensibs@gmail.com)
Experimental Model and Subject Details
Mice MiR-21 -/and miR-21 f/+ mice on the C57B6 background were from Shanghai Model Organisms (China). IL17A-eGFP reporter mice were from Biocytogen.
All mice were maintained under specific pathogen-free conditions. All animal experiments were performed in compliance with the guide for the care and use of laboratory animals and were approved by the institutional biomedical research ethics committee of the Shanghai Institutes for Biological Sciences (Chinese Academy of Sciences).
Cell culture
Naïve CD4 + T cells were isolated from lymph nodes or spleen of mice using a CD4 + CD62L + T cell isolation kit II (Miltenyi Biotec) according to the manufacturer's instruction. Naï ve CD4 + T cells were stimulated with platebound anti-CD3ε mAb (5 µg/ml) in the presence of anti-CD28 mAb (2 µg/ml) in a 48-well plate under neutral conditions (10 µg/ml anti-IL-4 mAb and 10 µg/ml anti-IFN-γ mAb), IL-6 conditions (10 ng/ml IL-6, 10 µg/ml anti-IL-4 mAb, and 10 µg/ml anti-IFN-γ mAb), TH17 (β) condition (2 ng/ml TGF-β1, 20 ng/ml IL-6, 10 µg/ml anti-IL-4 mAb, and 10 µg/ml anti-IFN-γ mAb), TH17 (23) condition (20 ng/ml IL-6, 20 ng/ml IL-1β, 20 ng/ml IL-23, 10 µg/ml anti-IL-4 mAb, and 10 µg/ml anti-IFN-γ mAb).
In vitro PTXF treatment
Naïve CD4 + T cells were differentiated under pathogenic TH17 (23) condition for 2 days, cells were collected and pre-incubated with 500 µg/mL PTXF or H2O
for 15 min at 37C. Total cells suspensions were then activated with 5 µg/mL plate-coated anti-mCD3, 2 µg/mL soluble anti-mCD28, 20 ng/ml IL-6, 20 ng/ml IL-1β, 20 ng/ml IL-23, 10 µg/ml anti-IL-4 mAb, and 10 µg/ml anti-IFN-γ mAb overnight at 37C.
Adenovirus transduction
For overexpression of GFP or c-Rel in nonpathogenic TH17 (β) cells, naïve CD4 + T cells were differentiated under nonpathogenic TH17 (β) condition for 2 days, then adenovirus supernatant containing GFP or c-Rel (Hanbio, Shanghai, China) was added and the cells were spun at 2000 rpm for 1.5 hr at 30C. After spin infection, the cells were cultured in TH17 (β) condition and harvested on day 5 for sorting of GFP + transduced cells.
Methods Details
Intracellular cytokine staining
Cultured or tissue isolated lymphocytes were washed and stimulated with PMA (50 ng/ml) plus ionomycin (750 ng/ml) for 4 h at 37°C. Cells were stained with anti-CD45 APC-cy7, anti-CD3ε PerCP5.5 and anti-CD4 BV510 for 30 min at 
RNA-seq
Naive CD4 + T cells from control and miR-21 -/mice were differentiated under pathogenic TH17 (23) differentiation condition. Total RNA was prepared from these cells using Trizol reagent (Invitrogen). RNA-seq libraries were prepared using a TruSeq Stranded Total RNA Library Prep Kit (Illumina). For GFP + TH17 cells sorted from in vivo suspensions, 50,000 cells were resuspended in 700 ul Trizol reagent, total RNA was prepared by miRNeasy Micro Kit (Qiagen), RNAseq libraries were prepared using SMART-Seq v4 Ultra Low Input RNA Kit (clontech). Sequencing was performed on an Illumina HiSeq X Ten System in a 150 bp/150 bp Paired end mode.
ATAC-seq
ATAC-seq library preparations were performed as described (Buenrostro et al., 2013) . In brief, 50,000 cells were washed in cold PBS and lysed. Transposition was performed at 37 °C for 30 min. After purification of the DNA with the MinElute PCR purification kit (Qiagen), DNA was amplified for 5 cycles.
Additional PCR cycles were evaluated by real time PCR. Final product was cleaned by Ampure Beads at a 1.5× ratio. Libraries were sequenced on a HiSeq X Ten System in a 150 bp/150 bp Paired end mode.
Metabolomics
The metabolomics profiling was performed on gas chromatograph-time-of-flight mass spectrometry (GC-TOFMS) as previously described (Chen et al., 2014; Chen et al., 2016; Liu et al., 2019) (Metaboprofile, Shanghai, China) .
MetaboAnalyst was used to analyze range-scale data and provide PCA and KEGG pathway analysis of metabolites changed (www.metaboanalyst.ca/).
Metabolism Assays
Extracellular acidification rate (ECAR) was determined using Seahorse Xfe24 analyzer (Agilent Technologies). Briefly, TH17 (β), TH17 (23), control and miR-21 -/-TH17 (23) cells (0.5x10 6 /well) were plated on Cell-Tak coated Seahorse culture plate for 30 min. ECAR, a measure of glycolysis was measured under basal conditions and in response to glucose (10 mM), Oligomycin (1.0 mM), 2deoxyglucose (2-DG) (50 mM) (Agilent seahorse XF glycolysis stress test kit).
Quantification and Statistical Analysis
ATAC-seq data processing ATAC-seq reads were trimmed using trim_galore 0.4.4_dev with the default settings then mapped to mm10 reference by bowtie2 (Langmead and Salzberg, 2012) with parameters '--end-to-end --no-unal -X 2000', low quality reads (MAPQ < 10), singletons and duplicated reads were removed using samtools (Li et al., 2009) . To call the differential accessible regions between samples, filtered bam files were down-sampled to the same fragments number and then processed by rgt-THOR with parameters '--pvalue 0.05 --binsize 100 --step 50' (Allhoff et al., 2016) . Differential peaks derived from rgt-THOR were further filtered according to their significant scores by cutting from the switch point in the rank plot. Enriched transcription factor binding motifs were searched by HOMER findMotifsGenome.pl (Heinz et al., 2010) using top 1000 differential accessible peaks centered by the peak summits and extended to +/-100bp.
RNA-seq data processing
RNA-seq reads were mapped to mm10 and refGene annotation transcriptome downloaded from UCSC Genome Browser using TopHat2 (Kim et al., 2013) , low quality reads (MAPQ < 10) were filtered by samtools, then gene level expression was count by htseq-count (Anders et al., 2015) using all refGenes.
Differential expressed genes were called by DESeq2 (Love et al., 2014) using FDR 0.05 and foldchange ≥ 1.5.
For other quantitative data, Prism software was used for statistical analysis.
Differences between groups were compared with an unpaired two-tailed t-test.
A P value of less than 0.05 was considered statistically significant. and Ileum TH17 (blue) with differential TH17 signature genes highlighted.
Figure Legends
DEGs are filtered as FDR < 0.05 and fold change ≥ 1.5 from DESeq2.
(B) Scatter plot shows differential expressed genes between CNS TH17 (red) and Ileum TH17 (blue) with glycolysis pathway genes highlighted and differential genes labeled.
(C) Scatter plot shows differential expressed genes between CNS TH17 (red) and Ileum TH17 (blue) with glutaminolysis pathway genes highlighted and differential genes labeled.
(D) CNS TH17 and Ileum TH17 cells depend on distinct metabolic pathways. Numbers indicate the differential expressed genes and total genes for each pathway.
(E) KEGG enrichment for CNS TH17 cell highly expressed genes.
(F) KEGG enrichment for Ileum TH17 cell highly expressed genes. (23) (red) and TH17 (β) cells (blue) with differential numbers labeled.
(B) ATAC-seq reads density heatmap around the OCRs between TH17 (23) and TH17 (β) cells.
(C) Enriched transcription factor motifs in top 1000 differential OCRs between TH17 (23) cells and TH17 (β) cells, color bar is -log10 (P value). Right panel shows the identified motif sequences for key regulators.
(D) Differential OCRs signals for key glycolytic genes in TH17 (23) and TH17 (β) cells. Arrows represent the NF-kB binding motif sites. (C) KEGG enrichment for genes downregulated in miR-21 -/-TH17 cells.
(D) Heat map of selected genes of interest in TH17 cell pathogenicity (left) and
in glycolytic pathway (right).
(E) RNA-seq data of glycolytic pathway genes from miR-21 -/-/control TH17 cell ratio plotted as a function of RNA-seq data from CNS/Ileum TH17 cell ratio.
(F) Extracellular acidification rate (ECAR) of TH17 (23) cells differentiated from control and miR-21 -/mice for 96 hs assessed by a glycolysis stress test. 
